bristol myers squibb holiday schedule 2021 bristol myers squibb holiday schedule 2021

Bristol Myers Squibb (NYSE: BMY) today announced that the company will participate in a fireside chat at the 2021 Bank of America Securities Virtual Health Care Conference, which will be webcast on Tuesday, May 11, 2021. Bristol Myers Squibb Chris Boerner, Ph.D., Executive Vice President, Chief Commercialization Officer will answer questions about the company at 5 p.m. Bristol-Myers Squibb's report follows an earnings beat by J&J on April 20, who reported EPS of $2.59 on revenue of $22.32B, compared to forecasts EPS of $2.34 on revenue of $21.98B. If, like us, you believe in the power of science to address some of the most challenging diseases of our time, then youll fit right in as we search for the next breakthroughs in biopharma. Bristol Myers Squibb is well positioned to build on our success in 2021 and continue to grow our company through the end of the decade. Following the successful closing of the tender offer, Bristol Myers Squibb will acquire all remaining shares of Turning Point Therapeutics that are not tendered into the tender offer through a second-step merger at the same price of $76.00 per share. This information is among the primary indicators that we use as a basis for evaluating performance, allocating resources, setting incentive compensation targets and planning and forecasting for future periods. Bristol-Myers Squibb 2021: Mark Your Calendar. Both GAAP and non-GAAP guidance assume current exchange rates. Risk Evaluation and Mitigation Strategies (REMS), Pre-Approval Access to Investigational Medicines, Areas of Interest & Competitive Research Grants, The Thomas O. Daniel Research Incubator and Collaboration Center, Acquisition FAQs for Celgene Shareholders, Acquisition-related information for Celgene shareholders, Unsubscribe to News Email Alerts - Bristol Myers Squibb, Subscribe to New Email Alerts - Bristol Myers Squibb, BMS at June 2022 oncology and hematology congresses, Committed to creating a better future for cancer patients, People & Business Resource Groups leadership team, Our Commitment to Equal Employment Opportunity, Access to Medicines in the Developing World, Standards of Business Conduct and Ethics. Holiday Calendar; Earnings Calendar; A sign stands outside a Bristol Myers Squibb facility in Cambridge, Massachusetts, U.S., May 20, 2021. A reconciliation of the forward-looking non-GAAP measures presented in this communication is not provided due to the inherent difficulty in forecasting and quantifying items that are necessary for such reconciliation. 0000002778 00000 n International revenues increased 4% to $4.5 billion in the quarter. Our Insights for Success program is offered to diverse employees to enhance their organizational and personal career success and ensure equitable leadership throughout the company. Turning Point Therapeutics is a clinical-stage precision oncology company with a pipeline of investigational drugs designed to address key limitations of existing cancer therapies. Upcoming events. In addition, the company believes such a reconciliation would imply a degree of precision and certainty that could be confusing to investors. Also note that a reconciliation of the forward-looking revenue (ex-FX), free cash flow and non-GAAP operating margin measures is not provided due to the inherent difficulty in forecasting and quantifying items that are necessary for such reconciliation. The financial guidance is subject to risks and uncertainties applicable to all forward-looking statements as described elsewhere in this press release. 813 0 obj Our financial strength, dedicated workforce and proven ability to execute will enable us to continue to advance our pipeline, invest in future sources of innovation and position the company for sustained growth., $ amounts in millions, except per share amounts. A dds details on agreement, background. A method of treating a disorder mediated by BRD9 comprising administering an effective amount of a compound of Formula: or a pharmaceutically acceptable salt thereof None of our operations have been identified as having significant risk for incidents of child labor or forced labor. Its primary focus is on cancer, cardiovascular, immunology and fibrotic therapeutic projects. With support and coaching from your colleagues, youre encouraged to take on stretch assignments that maximize your learning experience. NEW YORK--(BUSINESS WIRE)-- For more information about Bristol Myers Squibb, visit us at BMS.com or follow us on LinkedIn, Twitter, YouTube, Facebook, and Instagram. Minor Fasts . In addition, the compounds described in this communication are subject to all the risks inherent in the drug development process, and there can be no assurance that the development of these compounds will be commercially successful. If you have $1,000 at the ready, pharmaceutical stock Bristol Myers Squibb *Stock Advisor returns as of June 7, 2021. Stocks gain as Bostic backs quarter-point hike; Hewlett Packard Enterprise lifts annual guidance after Q1 results beat estimates; Fed wrestles whether recent data a 'blip' or a warning on inflation (EPS) for full-year 2021 between $3.18 and $3.38, up from its previous forecast of a range of $3.12 to $3.32. BMS Benefits and Work Life. Virtual Benefits Fair. Bristol Myers Squibb Paid Holidays 106 employees reported this benefit 4.3 20 Ratings Available to US-based employees Change location Employee Comments Showing 1-10 of 20 28 Jan 2023 4.0 Current Direcror in nullnull Comparable to many others in the same league Helpful Report 22 Dec 2022 4.0 These documents are available from the Securities and Exchange Commission, the Bristol Myers Squibb website or from Bristol Myers Squibb Investor Relations. FOURTH QUARTER PRODUCT REVENUE HIGHLIGHTS, *In excess of +100%. The transaction is subject to customary closing conditions, including the tender of a majority of the outstanding shares of Turning Point Therapeutics common stock and the expiration or termination of the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976. Our work is challenging and you shouldn't have to go it alone. We are honored to be recognized by Fortune once again as one of the Worlds Most Admired Companies. I am confident in our ability to execute against key milestones in 2022, including three planned first-in-class launches with the fixed dose combination of relatlimab plus nivolumab, mavacamten and deucravacitinib. Warnings Bristol-Myers Squibb Co and Eisai Co said on Thursday they had entered into an agreement worth up to $3.10 billion to jointly develop and market an experimental cancer drug. they used to have flexible schedules- though that is unfortunately being phased out. The FDA has accepted the NDA and the EMA has validated the Marketing Authorization Application for deucravacitinib for the treatment of adults with moderate to severe plaque psoriasis. Bristol Myers Squibb posted third quarter revenues of $11.2 billion, a decrease of 3%, driven by recent LOE products (primarily Revlimid) and foreign exchange impacts, partially offset by in-line products (primarily Eliquis and Opdivo) and our new product portfolio . No forward-looking statement can be guaranteed. Under the terms of the merger agreement, Bristol Myers Squibb will promptly commence a tender offer to acquire all of the outstanding shares of Turning Point Therapeutics common stock at a price of $76.00 per share in an all-cash transaction for a total consideration of $4.1 billion in equity value. The financial guidance is subject to risks and uncertainties applicable to all forward-looking statements as described elsewhere in this communication. Forward-looking statements are based on current expectations and projections about the companys future financial results, goals, plans and objectives and involve inherent risks, assumptions and uncertainties, including internal or external factors that could delay, divert or change any of them in the next several years, that are difficult to predict, may be beyond the companys control and could cause the companys future financial results, goals, plans and objectives to differ materially from those expressed in, or implied by, the statements. Total Rewards may differ based on country; the benefits described on this site are specific to those in the U.S. Listen to Webcast. Because the non-GAAP financial measures are not calculated in accordance with GAAP, they should not be considered superior to and are not intended to be considered in isolation or as a substitute for the related financial measures presented in the press release that are prepared in accordance with GAAP and may not be the same as or comparable to similarly titled measures presented by other companies due to possible differences in method and in the items being adjusted. We incorporate security and human rights in our assessment of countries when determining where to locate operating facilities. Agenus saw its stock skyrocket on Tuesday after the company announced a $1.6 billion deal with Bristol-Myers Squibb (NYSE: BMY), a $146 billion giant, to develop Agenus promising new cancer antibody treatment. The Office of Corporate Conduct is a resource for any employee to confidentially and anonymously report their concerns or raise questions. New Year's Day Martin Luther King Presidents Day Memorial Day July 4th Labor Day Thanksgiving and Day After Christmas Day Chevron Sara Kashima SKSH@chevron.com President's Day is only a holiday for those on the traditional 5/40 schedule. The acquisition of Turning Point Therapeutics further broadens our leading oncology franchise by adding a best-in-class, late-stage precision oncology asset, said Giovanni Caforio, M.D., Board Chair and Chief Executive Officer, Bristol Myers Squibb. (PDF), UK-CA Slavery and Human Trafficking Statement (PDF), Our Commitment to Global Inclusion & Diversity>. Bristol Myers Squibb (NYSE:BMY) and Turning Point Therapeutics, Inc. (NASDAQ:TPTX) today announced a definitive merger agreement under which Bristol Myers Squibb will acquire Turning Point Therapeutics for $76.00 per share. 866 0 obj 0000001987 00000 n 0000003347 00000 n Find out why possibility lives at Bristol Myers Squibb, We demonstrate ethics, integrity and quality in everything we do for patients, customers and colleagues, We pursue disruptive and bold solutions for patients, We move together with speed and quality because patients are waiting, Our dedication to learning and excellence helps us to deliver exceptional results, We all own BMS success and strive to be transparent and deliver on our commitments, We embrace diversity and foster an environment where we can all work together at our full potential. <> 813 55 0000001396 00000 n Case Timeline November 12, 2021 PRESS RELEASE: FTC Approves Modifications to Bristol Meyers Squibb Divestiture Agreement January 13, 2020 File Complaint (112.81 KB) File As a result, the reconciliation of these non-GAAP measures to the most directly comparable GAAP measures is not available without unreasonable effort. ** Included as part of the new product portfolio endstream trailer When adjusted for foreign exchange impact, international revenues increased 7%. customer.relations@bms.com (877) 517-6326 (Monday-Friday, 8 AM-8 PM ET) Adverse event or product quality complaints (800) 721-5072 Operating expenses, consisting of marketing, selling and administrative expenses and research and development expenses, are expected to decrease by approximately 10% for GAAP and be in-line with 2021 levels for non-GAAP. Additional Information about the Tender Offer and Where to Find it. There are regular US holidays with 4 floating holiday/personal days.